Hepatocellular carcinoma in Hepatitis C genotype 4 after viral clearance and in absence of cirrhosis: two case reports. Academic Article uri icon

Overview

abstract

  • Genotype 4 Hepatitis C virus represents approximately 20% of global Hepatitis C virus infection and is the source of a considerable burden to health-care providers across the globe. Many studies reported that interferon reduces the risk of hepatocellular carcinoma in patients with chronic hepatitis C.Hereby, we are reporting two cases of hepatocellular carcinoma in Hepatitis C virus-genotype 4 after complete viral eradication and in absence of cirrhosis. We aim to highlight the possible direct oncogenic effect of Hepatitis C virus-genotype 4, particularly with concomitant bilharzial infection and the importance of life-log follow up of these patients even in absence of cirrhosis.

publication date

  • September 15, 2009

Identity

PubMed Central ID

  • PMC2827147

Scopus Document Identifier

  • 9144237413

Digital Object Identifier (DOI)

  • 10.1086/380202

PubMed ID

  • 20181199

Additional Document Info

volume

  • 2